Healthscope Ltd (ASX: HSO) has announced it has received another takeover offer from the BGH – AustralianSuper Consortium.
Healthscope is one of the largest private hospital businesses in Australia.
The takeover offer:
Healthscope said that the takeover offer was substantially the same as the previous one made six months ago by the BGH – AustralianSuper Consortium, particularly with the same offer price of $2.36 per share. Healthscope subsequently rejected that offer.
The proposal is preliminary and a non-binding indication of interest, so there is no guarantee of success.
There are a large number of conditions including due diligence, arranging debt for acquisition, receiving investment committee approval from the Consortium’s members, all regulatory approvals and a few operational conditions.
The Consortium also requires Healthscope to not sell its property assets, to remain on track for 10% hospital profit growth in FY19 and that the balance sheet’s debt position is in line with the FY18 result.
Ellerston Capital, a Healthscope shareholder, has indicated to Healthscope it would be supportive of granting due diligence and would support a takeover offer.
The Healthscope share price has risen 18.2% in early trade to $2.11. Healthscope recently revealed a 50% decrease of profit in the FY18 result.
Slow News Day? Here’s A Great Story…
The Rask Group’s Australian Investors Podcast is fast becoming Australia’s #1 podcast for serious investors. It provides unique insights from Australia’s best investors, entrepreneurs, authors and financial thinkers. Download the latest episode free on iTunes, Castbox, YouTube or wherever you choose to listen.
*As voted by us
